Abstract
In this issue of Blood, Bruns et al report that hematopoietic stem and progenitor cells are significantly decreased in the bone marrow of multiple myeloma (MM) patients. Based on their insightful findings the authors claim that hematopoietic suppression depends on cues (eg, the activation of TGFβ signaling pathways) within the MM milieu and is reversible in a MM-free bone marrow microenvironment.
| Original language | English |
|---|---|
| Pages (from-to) | 2539-2540 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 120 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 27 Sept 2012 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Animals
- Antigens, CD34/metabolism
- Biomarkers/metabolism
- Bone Marrow/pathology
- Female
- Hematopoietic Stem Cells/pathology
- Humans
- Male
- Megakaryocyte-Erythroid Progenitor Cells/pathology
- Multiple Myeloma/metabolism
Fingerprint
Dive into the research topics of 'MM-associated anemia: more than "crowding out" HSPCs'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver